Amorphous kinase inhibitor formulations and methods of use thereof | Patent Publication Number 20220031677

US 20220031677 A1

Patent NumberUS 11576903 B2

Application Number17504133

Filled DateOct 18, 2021

Priority DateDec 30, 2019

Publication DateFeb 3, 2022

Original AssigneeDeciphera Pharmaceuticals Llc

Current AssigneeDeciphera Pharmaceuticals Llc

Inventor/ApplicantsCorey Bloom
Fred Jordan
Scott Bone
Michael D. Kaufman

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.